miR‐375 induces adipogenesis through targeting Erk1 in pancreatic duct cells under the influence of sodium palmitate

Author(s):  
Selda Gezginci‐Oktayoglu ◽  
Serap Sancar ◽  
Ayse Karatug‐Kacar ◽  
Sehnaz Bolkent
2009 ◽  
Vol 96 (3) ◽  
pp. 536a-537a
Author(s):  
Viktoria Venglovecz ◽  
Peter Hegyi ◽  
Zoltan Rakonczay ◽  
Barry Argent ◽  
Michael A. Gray

2002 ◽  
Vol 159 (2) ◽  
pp. 303-312 ◽  
Author(s):  
Yves Heremans ◽  
Mark Van De Casteele ◽  
Peter in't Veld ◽  
Gerard Gradwohl ◽  
Palle Serup ◽  
...  

Regulatory proteins have been identified in embryonic development of the endocrine pancreas. It is unknown whether these factors can also play a role in the formation of pancreatic endocrine cells from postnatal nonendocrine cells. The present study demonstrates that adult human pancreatic duct cells can be converted into insulin-expressing cells after ectopic, adenovirus-mediated expression of the class B basic helix-loop-helix factor neurogenin 3 (ngn3), which is a critical factor in embryogenesis of the mouse endocrine pancreas. Infection with adenovirus ngn3 (Adngn3) induced gene and/or protein expression of NeuroD/β2, Pax4, Nkx2.2, Pax6, and Nkx6.1, all known to be essential for β-cell differentiation in mouse embryos. Expression of ngn3 in adult human duct cells induced Notch ligands Dll1 and Dll4 and neuroendocrine- and β-cell–specific markers: it increased the percentage of synaptophysin- and insulin-positive cells 15-fold in ngn3-infected versus control cells. Infection with NeuroD/β2 (a downstream target of ngn3) induced similar effects. These data indicate that the Delta-Notch pathway, which controls embryonic development of the mouse endocrine pancreas, can also operate in adult human duct cells driving them to a neuroendocrine phenotype with the formation of insulin-expressing cells.


Diabetes ◽  
2007 ◽  
Vol 56 (7) ◽  
pp. 1802-1809 ◽  
Author(s):  
S. Yatoh ◽  
R. Dodge ◽  
T. Akashi ◽  
A. Omer ◽  
A. Sharma ◽  
...  

2001 ◽  
Vol 281 (5) ◽  
pp. G1301-G1308 ◽  
Author(s):  
Tracy Greeley ◽  
Holli Shumaker ◽  
Zhaohui Wang ◽  
Clifford W. Schweinfest ◽  
Manoocher Soleimani

The mechanism of the pancreatic ductal HCO[Formula: see text] secretion defect in cystic fibrosis (CF) is not well defined. However, a lack of apical Cl−/HCO[Formula: see text] exchange may exist in CF. To test this hypothesis, we examined the expression of Cl−/HCO[Formula: see text] exchangers in cultured pancreatic duct epithelial cells with physiological features prototypical of CF [CFPAC-1 cells lacking a functional CF transmembrane conductance regulator (CFTR)] or normal duct cells (CFPAC-1 cells transfected with functional wild-type CFTR, CFPAC-WT). Cl−/HCO[Formula: see text] exchange activity, assayed with the pH-sensitive dye 2′,7′-bis(2-carboxyethyl)-5(6)-carboxyfluorescein in cells grown on coverslips, increased about twofold in cells transfected with functional CFTR. This correlated with increased apical 36Cl influx in cells expressing functional CFTR and grown on permeable support. Northern hybridizations indicated the induction of downregulated in adenoma (DRA) in cells expressing functional CFTR. The expression of putative anion transporter PAT1 also increased significantly in cells expressing functional CFTR. DRA was detected at high levels in native mouse pancreas by Northern hybridization and localized to the apical domain of the duct cells by immunohistochemical studies. In conclusion, CFTR upregulates DRA and PAT1 expression in cultured pancreatic duct cells. We propose that the pancreatic HCO[Formula: see text] secretion defect in CF patients is partly due to the downregulation of apical Cl−/HCO[Formula: see text] exchange activity mediated by DRA (and possibly PAT1).


2000 ◽  
Vol 118 (4) ◽  
pp. A196
Author(s):  
Alyssa M. Brown ◽  
Mary P. Bronner ◽  
Teri Brentnall ◽  
Peter S. Rabinovitch ◽  
Katie R. Carter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document